The current status of thrombosis and anticoagulation therapy in patients with COVID-19 in Japan: From the CLOT-COVID studyYuji Nishimoto, Yugo Yamashita, Sen Yachi et al.|Journal of Cardiology|2022Cited by 26
A Multicenter Prospective Observational Cohort Study to Investigate the Effectiveness and Safety of Rivaroxaban in Japanese Venous Thromboembolism Patients (The J’xactly Study)Yasuo Okumura, Hiroyoshi Yokoi, Masatoshi Koga et al.|Circulation Journal|2020Cited by 23
Incidence and Clinical Features of Venous Thromboembolism in Hospitalized Patients With Coronavirus Disease 2019 (COVID-19) in JapanYugo Yamashita, Norikazu Yamada, Yuuki Maruyama et al.|Institutional Repositories DataBase (IRDB)|2021Cited by 23
Influence of sex on development of thrombosis in patients with COVID-19: From the CLOT-COVID studyYugo Yamashita, Makoto Mo, Sen Yachi et al.|Thrombosis Research|2022Cited by 17
Incidence, risk factors, and clinical impact of major bleeding in hospitalized patients with COVID-19: a sub-analysis of the CLOT-COVID StudyJunichi Nakamura, Ichizo Tsujino, Sen Yachi et al.|Thrombosis Journal|2022Cited by 13